✦ LIBER ✦

Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer

✍ Scribed by Nogami, Naoyuki; Harita, Shingo; Ueoka, Hiroshi; Yonei, Toshiro; Kiura, Katsuyuki; Kamei, Haruhito; Tabata, Masahiro; Segawa, Yoshihiko; Gemba, Kenichi; Tanimoto, Mitsune

Book ID: 119318864
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 98 KB
Volume: 45
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2003.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of cisplatin, docetaxel an

Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)

✍ Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase I study of vinorelbine and irinote

Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

✍ Nanae Tomonaga; Yoichi Nakamura; Hiroshi Soda; Seiji Nagashima; Hirofumi Nakano; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 273 KB

Weekly chemotherapy with carboplatin, do

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study

✍ D Pectasides; A Visvikis; A Kouloubinis; J Glotsos; N Bountouroglou; N Karvounis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Phase I and pharmacokinetic study of pac

Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer

✍ T Kasai; M Oka; H Soda; J Tsurutani; M Fukuda; Y Nakamura; S Kawabata; K Nakatom 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Biweekly docetaxel-irinotecan with filgr

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

✍ Giuseppe Frasci; Pasquale Comella; Renato Thomas; Maurizio Di Bonito; Liliana La 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 811 KB

Biweekly docetaxel-irinotecan with filgr

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

✍ Giuseppe Frasci; Pasquale Comella; Renato Thomas; Maurizio Bonito; Liliana Lapen 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB